Results 291 to 300 of about 141,600 (335)
Novel approaches for drug development against chronic primary pain: A systematic review
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade +7 more
wiley +1 more source
A Cruel Choice: Patients Forced to Decide Between Medical Marijuana and Employment
Ari Lieberman, Aaron Solomon
openalex +1 more source
Abstract Background and Purpose New synthetic cannabinoid receptor agonists (SCRAs) are associated with severe adverse effects, including unexpected psychiatric symptoms. These compounds are mainly active through their potent agonism on the cannabinoid receptors CB1 and CB2.
Giorgia Corli +8 more
wiley +1 more source
Summaries for the Fourth Annual IRS/SJSU Small Business Tax Institute [PDF]
Grey, Aaron +5 more
core +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Home Healthcare Now, 2016
The use of medicinal marijuana is increasing. Marijuana has been shown to have therapeutic effects in certain patients, but further research is needed regarding the safety and efficacy of marijuana as a medical treatment for various conditions. A growing body of research validates the use of marijuana for a variety of healthcare problems, but there are
+6 more sources
The use of medicinal marijuana is increasing. Marijuana has been shown to have therapeutic effects in certain patients, but further research is needed regarding the safety and efficacy of marijuana as a medical treatment for various conditions. A growing body of research validates the use of marijuana for a variety of healthcare problems, but there are
+6 more sources
Medical and Recreational Marijuana
AJN, American Journal of Nursing, 2021Information for nurses, patients, and the public.
Delene, Volkert, Tracy A, Ortelli
openaire +2 more sources
Physicians and Medical Marijuana
American Journal of Psychiatry, 2012Psychiatrists may be asked by patients for referrals for medical marijuana under legislation in a number of states. There is no clinical scientific literature to support benefits. Risks to the patient include a supply whose purity and potency are not specified.
Herbert D, Kleber, Robert L, DuPont
openaire +2 more sources
Medical marijuana in neurology
Expert Review of Neurotherapeutics, 2014Constituents of the Cannabis plant, cannabinoids, may be of therapeutic value in neurologic diseases. The most abundant cannabinoids are Δ(9)-tetrahydrocannabinol, which possesses psychoactive properties, and cannabidiol, which has no intrinsic psychoactive effects, but exhibits neuroprotective properties in preclinical studies.
Selim R, Benbadis +9 more
openaire +2 more sources
Marijuana: Modern Medical Chimaera
Journal of Drug Education, 2012Marijuana has been used medically since antiquity. In recent years there has been a resurgence of interest in medical applications of various cannabis preparations. These drugs have been cited in the medical literature as potential secondary treatment agents for severe pain, muscle spasticity, anorexia, nausea, sleep disturbances, and numerous other ...
openaire +2 more sources

